JW Pharmaceutical Losartan Potassium Tablet 100 mg (Losartan Potassium)
Losartan Potassium
Prescription medication
JW Pharmaceutical Co., Ltd.
MFDS item code 200713688 · Notified 2007.12.26
This product's status changed to Approval withdrawn on 2023.06.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and diabetic nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension
This medication is used to effectively control blood pressure in patients with hypertension. It is especially helpful in treating nephropathy in patients with type 2 diabetes. It is useful for preventing and improving hypertension and related kidney complications. Therefore, this drug is effective in managing kidney problems caused by hypertension and diabetes together. It helps maintain stable blood pressure according to the patient's health condition.
This medicine may be taken regardless of meals, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to 100 mg once daily if necessary. 2) Older adults No adjustment of the initial dose is necessary in older adults 75 years of age or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 4) Patients with reduced intravascular effective blood volume For patients who may have reduced intravascular effective blood volume (intravascular volume depletion) (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 5) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment. 7) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors).
Children and adolescents 6 years of age and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for pediatric patients under 6 years of age. Not recommended for pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡. Not recommended for pediatric patients with hepatic impairment.
This drug can cause serious harm to the fetus if taken during pregnancy, especially during the second and third trimesters, and should be discontinued immediately if pregnancy is confirmed. Individuals who are allergic to this drug or its components, pregnant women or women who may become pregnant, patients with severe liver dysfunction, and those with certain hereditary diseases should not take this drug. Elderly patients, those with reduced kidney function, patients with high serum potassium levels, and those with cardiovascular diseases should exercise particular caution when using this drug and should take it carefully under the guidance of a physician. Dizziness or symptoms of low blood pressure may occur while taking this medication, so care should be taken when performing activities that require alertness, such as driving or operating machinery. This drug can affect the liver or kidneys, so patients with liver or kidney diseases should have regular check-ups to monitor their condition. Interactions may occur when taken with other drugs; particularly, those taking potassium-sparing diuretics, potassium supplements, non-steroidal anti-inflammatory drugs, or lithium should consult their doctor. This medication is not recommended for breastfeeding women, and it is advisable to discontinue breastfeeding while taking it. It is safest not to administer this drug to children, particularly those under 6 years old or those with severely impaired kidney function. In case of overdose, hypotension and bradycardia may occur, and immediate medical assistance should be sought, with treatment being administered appropriately according to the symptoms. If any adverse reactions occur while taking this medication, consult a doctor immediately, especially if symptoms such as angioedema, severe allergic reactions, severe liver dysfunction, or acute renal failure appear, as swift treatment is necessary. This medication should be kept out of reach of children and should not be stored in other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius. This way of storage can help maintain the drug's effectiveness.
White, drop-shaped film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Losartan Potassium
Prescription medication
JW Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.